- Home
- Companies
- australasia
- clinical study
Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Food and Beverage
- Environmental
- Chemical & Pharmaceuticals
- Agriculture
- Health and Safety
- Air and Climate
- Government
- Energy
- Defense
- Waste and Recycling
- Oil, Gas & Refineries
- Water and Wastewater
- University / Academia / Research
- Manufacturing, Other
- Construction & Construction Materials
Clinical Study Suppliers In Australasia
28 companies found
based inSalt Lake City, UTAH (USA)
Everything we do is designed to help you develop, manufacture and commercialize products that help people live longer, healthier and more enjoyable lives. Being a global leader starts with a commitment to being local. MasterControl has deep ...
based inNürnberg, GERMANY
Alma is a global innovator of Laser, Light-based, Radiofrequency, Plasma and Ultrasound solutions for the aesthetic and surgical markets. We enable practitioners to offer safe and effective procedures while allowing patients to benefit from ...
Harmony XL PRO is a powerful and versatile treatment solution for a wide range of aesthetic needs. Treating over 65 FDA-cleared indications, this multi-application platform offers a full spectrum of technologies, applicators, tips and treatment ...
based inBox Hill North, AUSTRALIA
Magellan is a private Australian company with expertise in research, development and manufacturing of stem cells for the treatment of osteoarthritis. We lead the way globally in scientific, clinical and commercial expertise for stem cell supply and ...
Our product MAG200 has successfully completed Phase I/II of a clinical trials on the use of allogeneic (donor) off-the-shelf stem cell therapy for OA. The pivotal Phase III trial is planned to commence 2023. ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
DEP® docetaxel is an enhanced version of docetaxel (Taxotere®) – widely used for breast, lung & prostate cancer. Docetaxel (Taxotere®) is a commonly used chemotherapy agent despite having multiple US FDA “Black Box” ...
based inTorrance, CALIFORNIA (USA)
Phenomenex isn’t your typical scientific company. Founded nearly 40 years ago, Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers ...
based inEast Brisbane, AUSTRALIA
Ellume is a digital diagnostics company that develops, manufactures, and commercializes high-performance, connected products for healthcare professionals and consumers. It is at the forefront of accurate, rapid and accessible testing that is ...
ellume·lab is a versatile, handheld digital device designed for healthcare professionals at the point of care. ellume·lab offers a growing range of highly accurate, rapid diagnostic tests for the detection of common infectious ...
based inMawson Lakes, AUSTRALIA
Carina Biotech is an Australian pre-clinical immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. CAR-T therapy is a revolutionary new treatment option that uses a ...
Advanced colorectal cancer currently has a poor prognosis and is the deadliest form of cancer for Australians 25 to 34 years old. LGR5 is a cancer stem cell marker that is highly expressed on advanced colorectal cancer and other cancers. In colon ...
based inMascot, AUSTRALIA
Since 2006, AusDiagnostics has been committed to bringing the benefits of molecular science to the world, to help enable better diagnostic decisions in human diagnostics, animal diagnostics and applied testing. The first MT-PCR panel was introduced ...
based inNedlands, Perth, AUSTRALIA
Proteomics International is a pioneering medical technology company operating at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and ...
Proteomics International has developed a versatile platform technology for discovering diagnostic tests based on the differences in the protein make-up of people with and without a particular disease. By comparing blood or other samples taken from ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
MPC-25-IC is Mesoblast’s Phase 2 product candidate for the treatment of acute myocardial infarction. This is the first clinical study to evaluate an allogeneic cellular therapy delivered by intracoronary ...
based inLund, SWEDEN
Camurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New drug products are based on our ...
based inCambridge, MASSACHUSETTS (USA)
TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research ...
Ask the healthcare organizations who share their de-identified patient data to participate in your clinical study, right on our platform. Our live regional networks attribute each de-identified patient in your ...
based inCottesloe, AUSTRALIA
Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...
EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II. ...
based inDunedin,, NEW ZEALAND
Pacific Edge is a cancer diagnostics company. We specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Our ...
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
based inMontreal, QUEBEC (CANADA)
Novatek International provides a new breed of all-encompassing, process-driven laboratory information management system (LIMS) and other software solutions that target the pharmaceutical, biotech and other healthcare industries. Our unique portfolio ...
In clinical studies, assessing and managing risks, as well as establishing areas of uncertainty that contribute to risk, are critical to a company’s decision making processes. Many business units within ...
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
Biotechnology research is an ever-evolving area of science that requires nimble teams and customized solutions. We have a track record of developing advanced therapeutics with limited resources and tight timelines. Our team has extensive biotech and ...
based inNorth Ryde, AUSTRALIA
Biotron Limited (Biotron) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of ...
Biotron is developing novel small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and ...
based inBridgend, UNITED KINGDOM
Markes International is a specialist manufacturer of instrumentation for detection of trace-level volatile and semi-volatile organic compounds (VOCs and SVOCs). Markes has a well-deserved reputation for its application expertise in the field of ...
Markes’ BioVOC-2™ breath sampler is a lightweight and simple-to-use device designed for non-invasive biological exposure monitoring of VOCs. Using a design pioneered by the UK Health & Safety Executive, BioVOC-2 collects the last 129 ...
based inCarlsbad, CALIFORNIA (USA)
Founded and headquartered in Brisbane, Australia, ImpediMed is a global company with operations in the United States and Europe. We are the world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) ...
ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications—from laboratory research to clinic. The device has been used on species as varied as ...
based inSan Clemente, CALIFORNIA (USA)
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. At Glaukos, our focus is to develop and lead the ...
iStent inject® W is indicated for use in conjunction with cataract surgery for the reduction of IOP in adult patients with mild to moderate primary open-angle ...